Medicina Del Sol

01/03/2026

12/07/2025

Hey Doña Ana Medical Community, are you ready to embrace psychedelic healing for your patients who suffer with TRD, PTSD, SUD/AUD, and end of life distress due to a terminal illness? In one year New Mexico will have Medical Psilocybin, a breakthrough treatment for the above indications, as a formally registered program through the Department of Health. If you want to learn more about the science and supporting evidence or want to be trained as a prescriber or facilitator, you need to consider the Conscious Physician Psychedelic Academy (CPPA) program coming up in 2026. Dr. Lida Fatemi, DO and the dedicated and experienced faculty will provide didactics, mentorship, and practicums to support you in your training. If you’d like a presentation to your team before embarking on this endeavor, reach out to Dr. Deb Thorne, Executive Director of Sol Tryp and faculty member of the CPPA to arrange a time.
info@soltryp.org or call 575-570-1438

12/04/2025

The Conscious Physician: Psychedelics Academy (CPPA) is a pioneering training and mentorship platform created for physicians and healthcare professionals who feel called to explore psychedelic-assisted treatment through a grounded, ethical, trauma-informed pathway.
Founded by Dr. Lida Fatemi — palliative care physician, bestselling author, and internationally recognized educator — CPPA blends neuroscience, evidence-based medicine, and consciousness work to help clinicians heal themselves as they learn to heal others.
✨ What Makes CPPA Different?
• Clinician-centered, physician-led training
• Trauma-informed + somatic healing methods
• Integration of psilocybin, M**A & consciousness practices (where appropriate/legal)
• Deep cultural and global awareness
• A focus on healing burnout, moral injury & reconnecting to purpose
✨ Who Is CPPA For?
• Physicians exploring psychedelic-assisted treatment
• Healthcare workers navigating trauma, grief, or burnout
• Clinicians seeking a safer, more embodied approach to integrative healing
• Medical leaders bringing psychedelic literacy to their communities
CPPA’s mission is simple: Heal the healer. Heal the community. Evolve medicine.
If you're a clinician ready to step into this new era of conscious, compassionate care — CPPA is here to guide the way. 🌱

11/11/2025

Today we honor the courage, dedication, and sacrifice of all who have served.
Thank you to our veterans for protecting our freedom and inspiring us every day.
🇺🇸 Happy Veterans Day.

11/11/2025

This is a medical victory for women 🙌🏽💯 For years, perimenopausal/menopausal women had to suffer through exhausting vasomotor symptoms, sleepless nights, mood swings, weight gain, bone loss, hair loss, loss of muscle, etc because providers believed that HRT would cause dire consequences…all based on the very outdated and largely inaccurate findings from the Women’s Health Initiative study. This massive study caused more harm than good, sadly. For women who have had their HRT requests dismissed or denied by providers based on the old findings, schedule another appt and have another discussion! You deserve to feel whole again 🙌🏽💪🏽

The FDA will remove black box warnings on hormone replacement therapies after evidence showed the risks were overstated.

10/16/2025

https://www.facebook.com/share/1FWgtM499C/?mibextid=wwXIfr

The next generation of anti-inflammatory drugs might be inspired by psychedelics.

Psychedelics like L*D, DMT, and psilocybin are gaining attention for more than their hallucinogenic effects. New research suggests they could revolutionize how we treat chronic diseases driven by inflammation – without causing a psychedelic "trip."

Scientists have found that these compounds can lower key inflammatory markers like TNF-alpha, IL-6, and CRP – linked to conditions such as depression, asthma, arthritis, and even heart disease. Unlike steroid drugs, psychedelics may calm inflammation without weakening the healthy immune response.

In one study, a single dose of psilocybin reduced inflammation for a week. Another study showed ayahuasca lowered inflammation in people with treatment-resistant depression – and the bigger the drop, the greater the improvement in mood.

Surprisingly, the anti-inflammatory effects may not be caused by the same brain pathways that lead to hallucinations. That’s opened the door to a new class of medications: psychedelic-inspired drugs that don’t cause a “trip.”

Early candidates like DLX-001 and DLX-159 are already showing antidepressant effects in trials – without triggering hallucinations. These new compounds, sometimes called “PIPIs” (psychedelic-informed, psychedelic-inactive), could offer safe, effective treatments for millions.

Learn more:
"From trips to treatments: how psychedelics could revolutionise anti-inflammatory medicine." The Conversation, 6 October 2025.

10/13/2025

Our office is closed today to observe this important day.

09/21/2025

New Mexico’s health care crisis is forcing military personnel to decline assignments

At New Mexico’s three Air Force bases — Kirtland in Albuquerque, Cannon near Clovis and Holloman outside of Alamogordo — the lack of specialty medical care is a major deterrent

09/04/2025

🚨 Support Needed 🚨
We’re raising funds to make psychedelic integration support accessible for everyone — through free workbooks, scholarships, and community programs.
If you’ve ever believed in the healing power of psychedelics, now’s the time to help: https://www.gofundme.com/manage/enxe2p-support-lgbtq-youth-this-pride-month/edit

Even $25 covers a workbook for someone in need. 🙏 Please donate or share to spread the word!